Cydar Medical, a medical technology company focussed on endovascular imaging, today announced an exclusive commercial partnership with Patient1st Consult, Germany, a specialist provider of interventional medical devices and technologies in Germany, Austria and Switzerland (DACH).
“We are pleased to partner with Patient1st to expand the commercial availability of the Cydar EV platform to physicians and healthcare providers throughout DACH,” said Tom Carrell, CEO of Cydar Medical. “This strategic partnership expands our commercial capabilities in the region, with a partner experienced in supplying leading-edge technologies to medical specialists performing life-saving interventional and minimally-invasive vascular and endovascular procedures. We are confident that Patient1st Consult’s specialised team will enhance physician adoption and utilisation of our cloud based, AI navigation, guidance and planning technologies.”
Julian Rieck, CEO of Patient1st, commented, “We are excited to collaborate with the Cydar EV platform, which enables clinicians, payors and hospitals the opportunity to provide safer, predictable and optimised treatment to their patients. 11 years ago I started with planning tools for these procedures and it is intriguing that this exclusive partnership agreement will hopefully bring planning and procedure guidance even closer together with this fascinating technology. We believe that it will enable physicians to make procedures easier and improve patient outcomes.”
About Cydar Medical
Cydar Medical are the only company in the world using cloud computing, AI and computer vision to improve performance during image-guided surgery. Cydar EV enables surgeons to create detailed 3D Maps to plan surgery, and then automatically augments the live image guidance used during surgery with these Maps. The result is that surgeons can work more accurately and efficiently with better outcomes for patients.
About Patient1st Consult
Patient1st Consult facilitates market access for innovative cardiovascular technologies into the DACH region. Our 10+ year expertise ranges from software & IT solutions to disruptive single-use medical devices. For more information visit Patient1st Consult.